Skip to main content

Senior Lancet editor sacked

Global health advocate Rhona MacDonald has been fired from her position as senior editor at __The Lancet__ for what she describes as a violation of the confidentiality policy held by the journal's publisher Elsevier. MacDonald, who had worked at __The Lancet__ for more than three years, said that she was disciplined for sending out a draft and a final version of an editorial she said she wrote about the future of the United Kingdom's Department for International Development (DFID) -- which over

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Global health advocate Rhona MacDonald has been fired from her position as senior editor at __The Lancet__ for what she describes as a violation of the confidentiality policy held by the journal's publisher Elsevier.
MacDonald, who had worked at __The Lancet__ for more than three years, said that she was disciplined for sending out a draft and a final version of an editorial she said she wrote about the future of the United Kingdom's Department for International Development (DFID) -- which oversees the country's international development and poverty reduction efforts -- to several third parties. MacDonald emailed the two versions of the editorial to colleagues and sources she'd interviewed on background for the piece because, according to a statement she emailed to __The Scientist__, __The Lancet__'s editor, Richard Horton, "changed the whole meaning of the editorial without giving me...the opportunity to make any comments or suggestions before the editorial went to press." "I was completely scandalized," MacDonald told __The Scientist__. Prior to 1997, under a UK government run by the Conservative Party, the UK's global aid efforts were coordinated by the Overseas Development Administration, a wing of the Foreign and Commonwealth Office (FCO), and focused mainly on economic development. In 1997, the DFID was formed as a separate entity with its own cabinet-level minister at the helm. The linkurl:editorial;https://download.thelancet.com/pdfs/journals/lancet/PIIS0140673610604175.pdf -- which, like all editorials in the journal, is signed simply "__The Lancet__" -- was published in the journal's March 20th issue. It called upon the to-be-elected government to carefully consider the functional separation that exists between DFID and the FCO, and seemed to argue for returning to the strategy of combining global health and economic development efforts, a position held by the Conservative party, which triumphed in the recent elections. "The departmental division between development (including global health) and foreign policy weakens the UK's influence internationally," the published editorial read. "The current fragmentation of responsibilities weakens the UK's beneficial influence and dilutes the important contribution health can make not only to development but also to foreign policy." MacDonald's version, however, was much more complimentary of DFID, arguing that it be kept a separate and robust body to more adequately serve the global poor. "The thought of DFID ceasing to exist, or its policies to tackle poverty and poor health being watered-down or ripped up has lead us to appreciate, more keenly, what we, the UK, and the rest of the world, have in DFID," MacDonald's version stated in language missing from the published version. "Whatever happens at the next election, the groundbreaking work that DFID has started must carry on." "I think [the published editorial is] very harmful to poor people in the world," she said. "I was horrified." Angry at the changes, which MacDonald claimed were made at the 11th hour with very little opportunity to protest, she sent out emails seeking to dissociate herself from the published version after the piece went to press but before it appeared in __The Lancet__'s 20th March issue. Elsevier is keeping mum on this one. "We have respected the confidentiality of the circumstances of Rhona's departure from the company and wish to continue to do so," Elsevier spokesperson Tom Reller told __The Scientist__. "We consider it appropriate to make it clear that the company does not agree with the statements Rhona has made upon her departure, but we do not consider it appropriate to comment further." More on this developing situation to come on linkurl:the-scientist.com.;https://www.the-scientist.com/
**__Related stories:__***linkurl:Lancet retracts stem cell paper;https://www.the-scientist.com/blog/display/55003/
[5th September 2008]*linkurl:Elsevier's open access plan: Advertisers pay;https://www.the-scientist.com/blog/display/53577/
[10th September 2007]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo